Jabra Enhance Select M3 vs JLab Hear OTC

The Jabra Enhance Select M3 is a premium OTC hearing aid priced at $1,995, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This behind-the-ear device delivers strong overall performance, positioning it among the better-performing options in the OTC category. In our testing, the Enhance Select M3 showed notable strengths in speech clarity during quiet environments, scoring 3.8/5—a solid result that sits 0.95 points above the OTC category average. Music streaming quality also performs well at 2.8/5, which is 0.87 points above average for the category, though still mixed in absolute terms. Feedback handling is excellent at 4.6/5, ensuring stable performance during movement and daily activities. The device does show limitations in challenging listening environments. Speech in noise scored 1.3/5, which falls 0.18 points below the category average and represents a low absolute score. Users who frequently encounter noisy restaurants, busy social gatherings, or similar environments may find this a meaningful limitation. Own-voice comfort scored 2.7/5—above the category average by 0.18 points but only mixed in absolute terms. Consumers seeking strong performance in quieter settings with good music streaming capability may find the Enhance Select M3 appealing. However, shoppers should note that alternatives like the Sennheiser All Day Clear and Jabra Enhance Pro 20 at Costco offer comparable or higher scores at lower price points, potentially representing better overall value for budget-conscious buyers.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.